Improve Quality Of Life – Cannakids.org
“Where there is breath, there is hope!”
-by Veera Mahajan
Tracy Ryan of Cannakids and Robert Davidson of CURE pharmaceutical Corp. have a wonderful energy about them. It is evident they are a progressive duo that works together toward the common goal of enhancing the quality of life for children with cancer and their families. They will not stop just because the FDA has not approved cannabis oil in the US yet; in fact, they are excited about their work and future in this area of research and in obtaining FDA approval to bring the cannabinoid therapy to people in America and around the world. Rather than waiting idly, they are continuously working with researchers and labs in Israel and Canada to find new ways to produce better products that alleviate the battle against cancer, epilepsy, autism and beyond.
Tracy and Josh Ryan’s daughter Sophie was diagnosed with brain cancer at the age of 8 1/2 months old. After using cannabis oil in combination with her chemo protocol, Sophie’s tumor shrunk by over 95%, a tumor which doctors said minimal shrinkage would be the most likely scenario. Doctors also said Sophie would have partial, if not complete blindness, with zero chance of saving her vision. Now, with what is believed to be near perfect vision by her ophthalmologist, at almost four years old Sophie has become a medical miracle! She continues to defy many of the odds that doctors have placed against her, and leaves many of them in disbelief. After the Ryans witnessed the true medical benefits of cannabis oil first hand, Tracy took matters into her own hands and CannaKids was born.
CannaKids is a California based cooperative that focuses on supplying medical cannabis oil to adults and children looking for holistic relief for serious health conditions, with a focus on pediatric cancer.
Tracy has been working hard to find out what can help her daughter, as well as
other children living with cancer. She believes that there are other ways to treat cancer outside of Western medicine that do not cause the same painful side effects that chemotherapy does, and that through these alternate methods it is possible to live better and fuller lives. When she first began her quest to help cancer children, finding the resources she needed was an overwhelming task. Even after hundreds of hours of research, she still had questions and confusion.
Because of her experience with Sophie, Tracy understands how daunting it is to have a child with cancer and has built a website called SavingSophie.org with the latest cancer research and medical articles to help support families on the same journey. The site also raises funds to help other families in need, and offers support to families looking at holistic treatment alternatives. Through the website, the Tracy also hopes to alleviate stress through providing families with the necessary knowledge and tools to efficiently and effectively battle against the beast of a disease that is cancer.
CannaKids is different from its competitors because Ph.D. scientists, and organic chemists who specialize in medical cannabinoid formulation lead their oil production process. CannaKids offers a variety of medicinal cannabis products, which include: flavored THC tinctures, flavored CBD tinctures, Honey Gold CBD oil, Honey Gold THC oil, and THCA tinctures. They have partnered with pediatric and adult oncology nurses who specialize in cannabinoid therapy for many disease types, and provide recommended treatment plans specifically tailored to a patient’s ailment and existing pharmaceutical regimen.
A mutual friend introduced Tracy Ryan to her partner Robert Davidson. Tracy and Rob immediately felt they were a perfect fit to work together since they both had the same common goals in their desires to help save children. They were both already heavily immersed in the research side of cannabis, and by aligning their efforts they knew that they would be that much stronger!
On joining forces with Tracy and CannaKids, Davidson says, “I joined CannaKids due to its compelling stories and patient outcomes. It’s my goal to help CannaKids effectuate university research and to take a retrospective research approach on their past patient population. I think a meta-analysis of the data may yield some amazing insight into the medical cannabis world”.
It is hard enough for suffering families to endure constant surgeries and chemotherapy—at least they should have access to help in dealing with the pain and extremely harsh side effects. Tracy says that they have come a long way in a very short time, and are working with a local lab to hopefully roll out even more new products within the next 30 days.
The partnership between CannaKids.org and CURE Pharmaceutical Corp. was formed with the pure intension of promoting and providing an improved quality of life for children suffering with cancer and other chronic diseases like epilepsy, autism, PTSD, Crohn’s disease, fibromyalgia, ADD, ADHD, severe pain, anxiety and so much more. Tracy testifies that cannabis oils have tremendously helped patients with such diseases, and with research, she believes the results will only get better.
At the CURE Oxnard facility, everything, including every piece of equipment, is designed in-house by CURE personnel and built to FDA-approved standards. CURE is FDA registered and Good Manufacturing Practice (GMP) compliant. It manufactures pharmaceuticals, OTC drugs, dietary supplements, cosmetics and medical foods, all manufactured in a GMP Environment to meet food and drug federal regulations code Title 21. Cure does not currently manufacture any cannabis products in their facility due to federal regulations. Davidson adds, “Our goal is to facilitate as much research as possible on the potential health benefits of medical cannabis in some of these debilitating diseases”.
The CURE Oxnard facility includes the Mixing Room, where a process called homogenous blending takes place before the product is laid out in strips. The product is then cut into strips of different size, weight, thickness, and potency depending on each patient’s required dosage, which necessitates extreme precision. Thus throughout the production process for every Pharmaceutical product, there are 23 check points to ensure no discrepancies in any of these requirements exist. These strips are then packaged into rolls of about 8,000 strips to a roll. Cure Pharmaceutical would like to see a similar facility designed for medical cannabis oral thin film technology. CannaKids’ emphasis on quality of life and ensures that each of its patients are treated and cared for on individual, personalized basis. These custom-made, medical strips may run from $3.50 to $6.00 each in order to provide the highest level of effectiveness per patient. Ryan states, “They taste amazing, more active ingredient is able to get into the bloodstream since it’s being absorbed through the mucosal lining in the mouth instead of processing through the liver, and patients have reported effectiveness that supersedes any products they have ever tried in the past.
Chief executive officer Davidson has likewise explained that CURE is actively researching the perfect formulas for CannaKids. He states, “We are currently working with several research institutes overseas on several cannabis-related studies. Our goal is to expand our research efforts worldwide. There are so many different genetics of the cannabis plant that need to be studied. We are not sure which strains and variations of the full verse partial spectrum of the plant is more effective for each disease. Our major goal is to create a more focused approach to treatment”.
The practical benefits of using CURE strips as opposed to pills begin with their more compact packaging and easier usability. The amount of packaging required for thousands of pills to be transported to a third-world country, for example, not to mention the essential need for large amounts of clean water with which to take these supplements, makes pills relatively impractical. In contrast, supplements in strip form, as produced by CURE, solves all of these logistical problems. The rolls of strips are light and compact, easy to ship and to handle, with no water needed; taking supplements would not be a problem where clean drinking water is hard to find.
Chief Operations Officer Wayne Nasby of CURE explained that their Oxnard facility was actively started five and a half years ago. Initially they focused on building the facility and developing the technology; production of dietary supplements has taken place since 2 years ago. Though they currently operate on one 8-hour shift, CURE Oxnard has the capacity of running 3 shifts in the facility easily to produce many more products. According to Davidson, they want to produce dietary supplements and pharmaceuticals first, and prove the worth of their products before eventually producing products like CannaKids to help further improve quality of life.
Tracy Ryan is actively involved with CURE and its scientists in CannaKids’ research, whose products, she emphasizes, “are not dietary supplements”.
As Tracy explains, the FDA considers cannabis as schedule 1–highly toxic, addictive and very dangerous for human health—when there has never been a case of death. A rating of schedule 1 by the FDA also means that the product is not recognized as having any medicinal value; thus, research is not allowed in the US. If cannabis oils move to schedule 2, as Tracy and Robert hope, they can be researched and produced locally along with all other dietary and medicinal products.
Tracy says that people around the world have demonstrated proof of the healing properties of cannabis oils through anecdotal testimonies that span every disease you can fathom. Seeing the success that her own daughter has had, on top of the hundreds of patients she and her team have treated, there is just no denying the power of this incredible plant. The federal government even has a patent on it as a neuroprotectant, and many hospitals are interested in cannabis products as well. Institutes in Israel are moreover conducting research on cannabis and cancer. The studies have shown time and time again that cannabis actually does kill cancer. Research is continuing for the treatment of autism and epilepsy as well, and tests have shown that a child suffering from epilepsy can stop their seizures after a single dose of cannabis oil. Although Sophie has only had a few mild seizures in the last few months, they are under control simply through the adjustment of her cannabis doses, which is the only substance she uses—not epilepsy medicine.
Currently, CannaKids is working in partnership with labs in Israel and in Texas to do genomic sequencing on saliva, blood and tumor tissue to understand a person’s individual makeup. This way, doses can be based on how patients metabolize different substances, and what their bodies will and will not respond to. With the help of labs in Israel, CannaKids will also be able to figure out what types of cannabinoids are needed for the different genetic mutations of specific cancers in the very near future. Scientists who have been researching this for many years are soon hoping to be able to address even greater programs to include patients in United States. Once the FDA approves production, Davidson says, CannaKids will be ahead of the curve as they will be ready to roll out production of its products as soon as possible.
Davidson added that they are currently focusing on research and development and retrospective studies on CannaKids patient data. They are using their collective hospital connections to move the research and use of cannabis oil forward.
Cannakids.org is a California cooperative legally licensed to sell cannabis products to patients who have medical marijuana cards, or a caregiver card that allows parents to administer cannabis oil to a child under the age of 18 in accordance with California law.
According to scientific lab studies conducted in Israel, one strain of cannabis does not kill all disease. It may completely kill the disease in one cancer, but may not work the same way on a different type of cancer. More research needs to be done to understand what combinations of cannabinoids and terpenoids are required to kill the many different types of cancer. Thus, CannaKids never recommends that patients stop using Western medicine; cannabis is not a substitute for chemotherapy, but can be an enhancer to its efficacy, more effective when taken along with chemo to help it work better, more deeply, and reduce its negative side effects. Many hospitals in California are referring patients to CannaKids, as cancer kids on cannabis oil products can in many cases begin to gain weight and have a better life right away. It is common to see positive results after just the first dose.
CannaKids and CURE are working together with many researchers in Canada and Israel to develop standardized formulas and doses for individual patients. They intend to take production to pharmaceutical levels and soon bring it to the US.
CannaKids currently has a staff of eight people who are working with doctors in research and production. Most patients have come to them by word of mouth in hospitals, and through other patients all throughout California.
I am looking forward to working with Tracy and Robert to increase awareness of the positive values of this natural plant. After a lot of research, I now believe that Cannabis oils can assist in killing cancer. I feel privileged for the opportunity to help with the noble cause of bringing Quality of Life to young children and other patients suffering with terminal and chronic diseases. I am excited to be part of the team that cares!